Brief: Arocell Expands Arocell TK 210 Elisa In Europe

IDL Diagnostics AB (publ)

20/05/2021 07:51

May 20 (Reuters) - AroCell AB (publ)  AROC.ST :
    * AROCELL EXPANDS THE INDICATION OF USE FOR AROCELL TK 210
ELISA
IN EUROPE
    * AROCELL AB (PUBL) - ANNOUNCES TODAY EXPANSION OF
INDICATION FOR
USE FOR CE MARKED AROCELL TK 210 ELISA WITH CLINICAL USE IN
PROSTATE CANCER TREATMENT.

Source text for Eikon:  ID:nMFN7JfKYf 
Further company coverage:  AROC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))